Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
US Stock Insider Trading | Ptc Therapeutics disclosed 1 company insider transaction on March 13
On March 13, 2026, Ptc Therapeutics (PTCT) disclosed an insider trading transaction. Director Klein Matthew B. sold 2,662 shares on March 12, 2026.
【Recent Insider Transactions】
【Company Information】
Ptc Therapeutics, Inc. was incorporated on March 31, 1998, as a Delaware corporation. PTC Therapeutics is a biopharmaceutical company focused on oral drugs for post-transcriptional control processes, discovering and developing proprietary small-molecule medicines. The company’s research and development plans target multiple therapeutic areas, with a particular focus on developing and commercializing treatments for orphan and ultra-orphan rare diseases. The company’s leading candidate product is ataluren, which is used to treat a genetic disorder caused by a mutation known as nonsense mutation.